Saturday, 27 November 2021

Merck's COVID Drug Less Effective: Study

Molnupiravir drug against coronavirus revealed 30% less effective in decreasing the risk of hospitalization and deaths, revealed Merck's updated data.


from Medindia Health News https://ift.tt/3DYTG3r

No comments:

Post a Comment